Seeking Alpha

dreamdivers

dreamdivers
Send Message
View as an RSS Feed
View dreamdivers' Comments BY TICKER:
Latest  |  Highest rated
  • Rexahn: Recent Concerns Overshadowing a Robust Pipeline? [View article]
    Mr. Thomas, I am completely baffled as to your motivation for writing the article in the first place. The title, "Recent Concerns Overshadowing a Robust Pipeline?", suggests you believe there is a robust pipeline being overlooked at the moment. You, the author, then spend all of two whole sentences summarizing that possibly robust pipeline, and seem to want readers to analyze previous study data and pipeline potential for you in their comments.

    Again, I don't understand why anyone would write such a piece in the first place. If you don't understand the subject matter, and quite frankly you do don't seem to, it is not the audience's responsibility to educate you. Perhaps your objective was to make excuses for Mr. Garza's incredibly bad call on the stock back in February, in which case you failed that test as well.
    Mar 19, 2011. 09:32 AM | Likes Like |Link to Comment
  • Rexahn: Recent Concerns Overshadowing a Robust Pipeline? [View article]
    I am still trying to figure out if this whole article is a spoof, an early April Fool's prank. Talking about Mr. Garza's "stellar analysis" is truly comical. Mr. Garza's typical "analysis" seems to be limited to "certain unnamed company officials told me". There is invariably zero attempt to verify anything of importance with independent sources, to ask any hard questions, or to follow up later. In addition, Mr. Garza appears to have no background in science or medicine and little understanding of the industry, so he probably couldn't provide a real objective analysis even if he wanted to.

    Thus any frustrated small retailer you refer to is likely to be left holding the bag after a small initial run up on the "stellar analysis". Not really hard to understand after all.
    Mar 18, 2011. 12:00 PM | 1 Like Like |Link to Comment
  • Looking for Squeeze Pressure on Cleveland BioLabs [View article]
    Please identify which officials told you this. The company's own 10-K filed just two days ago states "We currently have drug substance corresponding to several hundred thousand projected human doses." Drug substance, as in bulk API, is not the same as a finished dose ready for use. Further, locating doses outside the US in case of a nuclear attack sounds almost ludicrous, what good would they be if they had to be transported from overseas after a nuclear attack when all the transportation and logistical systems were damaged? It's amazing that you continue to print this stuff.
    Mar 17, 2011. 03:32 PM | 1 Like Like |Link to Comment
  • Looking for Squeeze Pressure on Cleveland BioLabs [View article]
    Mr. Garza, you truly have no shame. Great short squeeze prediction there. Looks more like a typical P&D chart than anything else. Imagine that!
    Mar 17, 2011. 03:17 PM | 2 Likes Like |Link to Comment
  • Leaks From Japan's Nuclear Plants Could Send Cleveland Biolabs' Shares Beyond $20 [View article]
    I believe you mean that a big grant or purchase may be coming from BARDA IF and WHEN the drug candidate is approved by the FDA? You state its a fact or certainty, wehn it is not.
    Mar 14, 2011. 01:03 PM | Likes Like |Link to Comment
  • Leaks From Japan's Nuclear Plants Could Send Cleveland Biolabs' Shares Beyond $20 [View article]
    So in other words you are picking a number like $20 because of short-term disaster news? That's your whole thesis?
    Mar 14, 2011. 11:36 AM | Likes Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    So you make a significant mistake, and you want someone else to issue the correction? LOL

    No, at the time $16.8 million did not seem correct to anyone who really cared about accuracy and bothered to read the actual press releases. The press release on Feb. 2, a mere two days after the initial announcement of signing the agreement, clearly states "The Company has received approximately $7,500,000 in gross proceeds pursuant to the sale of convertible notes pursuant to the securities purchase agreement with net proceeds from the financing of approximately $6,820,000. The Company issued Convertible Promissory Notes in the aggregate principal amount of $8,437,500..." Is that really so difficult for you to understand? In addition, you don't seem to know the difference between gross proceeds, net proceeds, and aggregate principal amounts.

    I would like to believe that these were careless but innocent mistakes, rather than deliberate misstatements to help pump a stock. But you aren't helping much to that end.
    Mar 9, 2011. 03:00 PM | Likes Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    Mr. Bryant, I note that in your original SA "Revaluation" article on RPC on Feb. 7 you misstated the amount of total financing raised by RPC by $8.4 million, ie you claimed it $16.8 million when in fact it was only $8.4 million. Did you ever issue a correction to this misstatement, and if so where? And if not, why not?
    Mar 9, 2011. 01:35 PM | Likes Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    Before you use the word "libel", you should do some due diligence with the dictionary as well. Whether Mr. Bryant's advice on this particular stock is bad or not long-term remains to be seen. However, since the pps is down about 50% since his initial recommendation at $0.94, that hardly looks like good advice so far. And how have I libeled RPC itself or their marketing efforts?

    Good luck with that lawsuit against the NYSE, I'm sure they are just trembling with fear over that one.
    Mar 9, 2011. 12:05 PM | Likes Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    No I am not short or shorting RPC. I simply hate to see innocent people following bad advice, because they are unwilling or unable to do proper due diligence. But of course you were up 120% in 2010, no doubt about it. Yes, surely.
    Mar 9, 2011. 10:46 AM | Likes Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    Mr. Bryant, I just read your linked article "In my previous article, I broke down the company and showed that it is at least 65% undervalued." It contains numerous mistakes and incorrect assumptions. Perhaps you should have taken a basic course in finance, even Accounting 101, along with that chemistry course?

    First, you don't seem to understand what the word "debt" means. Secondly, you quote numbers on a small Chinese company like they are highly reliable figures. They are hardly ever reliable. Third, you actually double counted proceeds from the $8.4 Million Convertible Notes and Warrants Financing. It was $8.4 million gross, and $7.5 net, not $16 million total. Big difference. Finally, the $900k financing for Jade was described as a "bridge" financing, which in financial terms means Jade needed the money to do something and had no other financial means. So how does Jade have $17 million in assets and be set to earn $10 million profit this year (meaning turning a profit of almost the same $900k per month run rate), yet has no cash for legal and accounting expenses?

    I could go on, but I think you get the picture.
    Mar 9, 2011. 09:11 AM | 1 Like Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    Mr. Bryant, with all due respect, I do not believe the self-reported results of any stock picker on SA period. And before you sneer at 8% annually, it might not make you rich in the short-term, but it will help make you comfortably wealthy in the long-term. As for your 100% gainers, I have no doubt you have some 100% losers in there as well. The comments of some of the posters here remind me of people leaving a casino, funny how almost everyone claims to have come out ahead?
    Mar 9, 2011. 08:36 AM | 1 Like Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    Yes, but those companies are not going to lose 50% in one day. Nor are they being pumped solely by less than reputable (IMHO of course) sources like many small biotechs are. When you buy into momo runs started or fueled by those sources, sooner or later the hot air runs out and the balloon is going to come back to earth. Almost always a question or when, not if,and since you usually don't know when, you can't always get out quick as you plan to. Sorry for your loss, learn from it.
    Mar 8, 2011. 08:07 PM | Likes Like |Link to Comment
  • Radient Pharmaceuticals: Betting on Bullish Earnings and Positive Study Results [View article]
    Perhaps some of you fools will finally learn not to make investment decisions based on the advice of self-proclaimed "experts" like Mr. Bryant here. It is absolutely astounding to me that people consider him or any of the other blogger here a reliable source for information on any company, much less a biotech. If you guys are trading these things based on momo, and think you can get in and out before the music stops and all the chairs get taken, good luck to you. Sooner or later you're going to take a hit like this one, when it happens don't sit there and whine about it. it comes with the territory.
    Mar 8, 2011. 05:49 PM | Likes Like |Link to Comment
  • 3 Biotechs With Upcoming Catalysts [View article]
    Thanks again guys. Garza and BMR have an almost uncanny ability to pick great short candidates. Wait a few days or a week after the initial pump, and you are almost guaranteed to make money on the short side afterward. Works like a charm!
    Mar 6, 2011. 09:53 AM | 1 Like Like |Link to Comment
COMMENTS STATS
119 Comments
167 Likes